Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - carvedilol, quantity: 3.125 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; sucrose; povidone; crospovidone; colloidal anhydrous silica; magnesium stearate; iron oxide red - carvedilol watson is indicated for the treatment of hypertension. data have not been provided to support the use of this drug in renovascular disease. carvedilol watson is indicated for the treatment of patients with symptomatic mild to severe (nyha class ii-iv) congestive heart failure (chf) as an adjunct to conventional treatments (e.g. diuretics, digoxin, ace inhibitors and vasodilators).

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

aspen medical products malaysia sdn bhd - digoxin -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

aspen medical products malaysia sdn bhd - digoxin -

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

pharmacare limited û woodmead - tablet - see ingredients - each tablet contains digoxin 0,625 mg

Singapore - English - HSA (Health Sciences Authority)

celltrion healthcare singapore private limited - midodrine hcl - tablet - 5 mg - midodrine hcl 5 mg

Singapore - English - HSA (Health Sciences Authority)

dch auriga singapore - digoxin - elixir - 0.05 mg/ml - digoxin 0.05 mg/ml

United States - English - NLM (National Library of Medicine)

actavis elizabeth llc - metformin hydrochloride (unii: 786z46389e) (metformin - unii:9100l32l2n) - tablet - 500 mg - metformin hydrochloride tablets, as monotherapy, are indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes. metformin is indicated in patients 10 years of age and older. metformin may be used concomitantly with a sulfonylurea or insulin to improve glycemic control in adults (17 years of age nd older). metformin hydrochloride tablets are contraindicated in patients with: 1. renal disease or renal dysfunction (e.g., as suggested by serum creatinine levels ≥ 1.5 mg/dl [males], ≥ 1.4 mg/dl [females] or abnormal creatinine clearance) which may also result from conditions such as cardiovascular collapse (shock), acute myocardial infarction, and septicemia (see warnlngsand precautions). 2. congestive heart failure requiring pharmacologic treatment. 3. known hypersensitivity to metformin hydrochloride. 4. acute or chronic metabolic acidosis, including diabetic ketoacidosis, with or without coma. diabetic ketoacidosis should be treated with insulin. metformin should

United States - English - NLM (National Library of Medicine)

caraco pharmaceutical laboratories, ltd - glipizide (unii: x7wdt95n5c) (glipizide - unii:x7wdt95n5c), metformin hydrochloride (unii: 786z46389e) (metformin - unii:9100l32l2n) - tablet - 2.5 mg - glipizide/metformin hcl tablet is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. glipizide/metformin hcl tablet is contraindicated in patients with: - renal disease or renal dysfunction (e.g., as suggested by serum creatinine levels ≥ 1.5 mg/dl [males], ≥ 1.4 mg/dl [females], or abnormal creatinine clearance) which may also result from conditions such as cardiovascular collapse (shock), acute myocardial infarction, and septicemia (see warnings and precautions ). - known hypersensitivity to glipizide or metformin hydrochloride. - acute or chronic metabolic acidosis, including diabetic ketoacidosis, with or without coma. diabetic ketoacidosis should be treated with insulin. glipizide/metformin hcl tablet should be temporarily discontinued in patients undergoing radiologic studies involving intravascular administration of iodinated contrast materials, because use of such products may result in acute alteration of renal function. (see also precau

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

kyowa kirin international uk newco ltd - calcium carbonate; colecalciferol - chewable tablet - 1.5gram ; 400unit

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - calcium carbonate; colecalciferol - chewable tablet - 1.5gram ; 400unit